India - English - Central Drugs Standard Control Organization

corona - menotrophin (fsh & lh 1:1) - menotropins usp eq to the acitivity of follicle stimulating hormone (fsh) 75iu,luteinizing hormone (lh) 75iu,mannitol ip 12mg,po - vial

India - English - Central Drugs Standard Control Organization

corona - menotrophin (fsh & lh 1:1) - menotropins usp eq to the acitivity of follicle stimulating hormone (fsh) 75iu,luteinizing hormone (lh) 75iu,mannitol ip 12mg,po - vial

Singapore - English - HSA (Health Sciences Authority)

orient europharma pte ltd - triptorelin embonate 16.8 mg eqv triptorelin - injection, powder, lyophilized, for suspension - 11.25 mg - triptorelin embonate 16.8 mg eqv triptorelin 11.25 mg

Singapore - English - HSA (Health Sciences Authority)

orient europharma pte ltd - triptorelin embonate 31 mg eqv triptorelin - injection, powder, lyophilized, for suspension - 22.5 mg - triptorelin embonate 31 mg eqv triptorelin 22.5 mg

European Union - English - EMA (European Medicines Agency)

merck europe b.v. - follitropin alfa - anovulation; reproductive techniques, assisted; infertility, female; hypogonadism - sex hormones and modulators of the genital system, - anovulation (including polycystic ovarian disease, pcod) in women who have been unresponsive to treatment with clomiphene citrate.stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (art) such as in-vitro fertilisation (ivf), gamete intra-fallopian transfer (gift) and zygote intra-fallopian transfer (zift).gonal-f in association with a luteinising hormone (lh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. in clinical trials these patients were defined by an endogenous serum lh level

European Union - English - EMA (European Medicines Agency)

n.v. organon - follitropin beta - infertility; hypogonadism - sex hormones and modulators of the genital system, - in the female:puregon is indicated for the treatment of female infertility in the following clinical situations:anovulation (including polycystic ovarian syndrome, pcos) in women who have been unresponsive to treatment with clomifene citrate;controlled ovarian hyperstimulation to induce the development of multiple follicles in medically assisted reproduction programs (e.g. in-vitro fertilisation / embryo transfer (ivf/et), gamete intrafallopian transfer (gift) and intracytoplasmic sperm injection (icsi)).in the male:deficient spermatogenesis due to hypogonadotrophic hypogonadism.

European Union - English - EMA (European Medicines Agency)

theramex ireland limited - follitropin alfa - anovulation - sex hormones and modulators of the genital system, - in adult womenanovulation (including polycystic ovarian syndrome) in women who have been unresponsive to treatment with clomifene citrate;stimulation of multifollicular development in women undergoing superovulation for assisted reproductive technologies (art) such as in vitro fertilisation (ivf), gamete intra-fallopian transfer and zygote intra-fallopian transfer;ovaleap in association with a luteinising hormone (lh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. in clinical trials these patients were defined by an endogenous serum lh level < 1.2 iu/l.in adult menovaleap is indicated for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotropic hypogonadism with concomitant human chorionic gonadotropin (hcg) therapy.

United States - English - NLM (National Library of Medicine)

ferring pharmaceuticals inc. - follitropin (unii: 076whw89tw) (follitropin - unii:076whw89tw), luteinizing hormone (unii: 8xa4vn1lh4) (luteinizing hormone - unii:8xa4vn1lh4) - follitropin 75 [iu] in 1 ml - development of multiple follicles and pregnancy in ovulatory women as part of an assisted reproductive technology (art) cycle prior to initiation of treatment with menopur® (menotropins for injection): - perform a complete gynecologic and endocrinologic evaluation, and diagnose the cause of infertility - exclude the possibility of pregnancy - evaluate the fertility status of the male partner - exclude a diagnosis of primary ovarian failure menopur is contraindicated in women who exhibit: - prior hypersensitivity to menopur or menotropins products or one of their excipients - high levels of fsh indicating primary ovarian failure [see indications and usage (1)] - pregnancy menopur may cause fetal harm when administered to a pregnant woman [see use in specific populations (8.1)]. menopur is contraindicated in women who are pregnant. if this drug is used during pregnancy, or if the woman becomes pregnant while taking this drug, the woman should be apprised of the potential hazard to a fetus. - presence of unco

European Union - English - EMA (European Medicines Agency)

chemical works of gedeon richter plc. (gedeon richter plc.) - ganirelix acetate - reproductive techniques, assisted; ovulation induction; infertility, female - pituitary and hypothalamic hormones and analogues - prevention of premature luteinising hormone (lh) surges in women undergoing controlled ovarian hyperstimulation (coh) for assisted reproduction techniques (art).

Singapore - English - HSA (Health Sciences Authority)

roffe international holdings pte ltd - general hospital - this product is a rapid, one-step, visual test for the qualitative detection of follicle stimulating hormone (fsh) in human urine. it is intended for self-testing. it is to be used as a confirmation of body hormone changes related to the symptoms associated with the changes of menopause and as an adjunctive screen of fertility for home use by women who are attempting to conceive but have been unsuccessful. note: the test can not be used to determine ovulation. the test does not detect all kinds of fertility issues. the test may not be accurate if pregnant at the time of testing. the test can not be used for birth control.